Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,382 public trials 841 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?

NCT00945347

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Cliniques Universitaires St Luc (Université Catholique de Louvain) 10 avenue Hippocrate Brussels, Belgium

View Trial Details

Completed

A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

NCT00414908

Conditions: Chronic Disease, Chronic Pancreatitis, Digestive System Diseases, +9 more
Locations: Site 9 Scottsdale, Arizona, United States

Site 22 Bristol, Connecticut, United States

Site 7 Tampa, Florida, United States

Site 6 Atlanta, Georgia, United States

View all 30 locations

View Trial Details

Completed

Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00568646

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis

NCT01400750

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Department of pediatrics, CF center Uuiversity Hospital Leuven Leuven, Belgium

View Trial Details

Completed

A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency

NCT00401076

Conditions: Chronic Disease, Digestive System Diseases, Disease Attributes, +7 more
Locations: Site Reference ID/Investigator# 45211 Fukuoka, Japan

Site Reference ID/Investigator# 45297 Fukuoka, Japan

Site Reference ID/Investigator# 45220 Hiroshima, Japan

Site Reference ID/Investigator# 45279 Hiroshima, Japan

View all 17 locations

View Trial Details

Completed

A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency

NCT00400842

Conditions: Chronic Disease, Digestive System Diseases, Disease Attributes, +7 more
Locations: Site Reference ID/Investigator# 59845 Aichi, Japan

Site Reference ID/Investigator# 59933 Aichi, Japan

Site Reference ID/Investigator# 59928 Akita, Japan

Site Reference ID/Investigator# 59983 Amori, Japan

View all 98 locations

View Trial Details

Completed

Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.

NCT00308243

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University of Minnesota Medical School, The Minnesota Cystic Fibrosis Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer

NCT01396668

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Seoul National University Bundang Hospital Seongnam, South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer

NCT01396681

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Seoul National University Bundang Hospital Seongnam, South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

NCT00757237

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Anchorage, Alaska, United States

Phoenix, Arizona, United States

Tuscon, Arizona, United States

Orange, California, United States

View all 92 locations

View Trial Details